23 пациенти с метастатичен не- дребноклетъчен белодробен карцином (НДКБК).
Fatal pulmonary haemorrhage occurred in 2 patients receiving SUTENT on a clinical trial of patients with metastatic non-small cell lung cancer (NSCLC).